Ticker
  • Tequilita (5-2) returns to the winner's circle in the Grade 3 Charles Town Oaks.Posted 19 hours ago
  • Sharp Azteca (1-2) draws clear in the Grade 2 Kelso.Posted 23 hours ago
  • West Coast (4-5) leaves the field far behind in the Grade 1 Pennsylvania Derby.Posted 1 day ago
  • It Tiz Well (5-1) bests Abel Tasman in the Grade 1 Cotillion.Posted 1 day ago
  • Coal Front (4-5) refuses to let American Pastime by in the Grade 3 Gallant Bob.Posted 1 day ago
  • Page McKenney (6-1) digs down and holds on in the Pa Derby Champion Stakes.Posted 1 day ago
  • Off Limits (8-5) glides by her competition in the Grade 3 Noble Damsel.Posted 1 day ago
  • Capla Temptress (5-1) rolls home in the Natalma, while making her North American debut.Posted 7 days ago
  • Untamed Domain (3-1) kicks it in late to win the Summer Stakes at Woodbine.Posted 7 days ago
  • World Approval (2-1) shows he is much the best in the Grade 1 Woodbine Mile.Posted 7 days ago

RMTC Cites 'Major Gains' With Model Rules

Racing Medication and Testing Consortium
 
The horse racing industry made significant progress toward the uniform adoption of national medication reforms in 2014, as regulators in multiple jurisdictions adopted model rules developed by the Racing Medication and Testing Consortium (RMTC) and the Association of Racing Commissioners International. The new model rules include a Controlled Therapeutic Medications Schedule, third-party administration of furosemide, a multiple medication violation (MMV) penalty system and a requirement for laboratory accreditation and participation in an industry external quality assurance program. The past 12 months brought major gains in the number of jurisdictions that are presently operating or soon-to-be operating under one or more of the reforms. 
 
“Throughout 2014, the RMTC staff has traveled extensively and spent innumerable hours consulting with state regulators and others to assist in the full implementation of these new model rules that are so important to the safety and integrity of horse racing,” said Dr. Dionne Benson, executive director of the RMTC. “We thank all of those who have worked in good faith to accomplish an unprecedented level of uniformity in 2014, and look forward to continuing the effort in 2015 and beyond.”
 
By early 2015, racing states operating under the Controlled Therapeutic Medication Schedule are anticipated to increase from four to at least 16 – a 300% improvement since January 2014. The Schedule identifies medications that have been recognized as necessary for the routine treatment of illness or injury in the horse. Arkansas, California, Illinois, Indiana, Kentucky, Minnesota, New Jersey, New Mexico, New York, North Dakota, Oregon and West Virginia have or will soon join Delaware, Maryland, Massachusetts and Virginia in regulating therapeutic medications using the new Schedule.
 
By early 2015, the number of horse racing states utilizing RMTC-accredited labs and an external quality assurance program for their equine drug and medication testing services will increase from six to 23 – a 283% gain from just 12 months ago. The laboratory accreditation and quality assurance programs were built upon protocols established by the World Anti-Doping Agency, the gold standard in human competition.  Arizona, Arkansas, Colorado, Delaware, Idaho, Indiana, Maryland, Massachusetts, Minnesota, Nebraska, New Jersey, North Dakota, Oklahoma, Oregon, Washington, West Virginia and Wyoming have or will soon join California, Kentucky, Maine, New Mexico, Ohio and Virginia as states using only RMTC-accredited lab testing services.  Labs in New York and Pennsylvania are expected to be RMTC-accredited sometime in early 2015, and Texas has recently applied for RMTC accreditation.
 
States that have implemented the MMV penalty system will increase no less than 200%, from three in January 2014 to at least nine by early 2015. The MMV penalty system – designed to work in a manner similar to the way states track an individual’s traffic violations – provides for enhanced penalties for individuals who accumulate multiple medication violations, regardless of the jurisdiction in which they occur. Arkansas, Colorado, Indiana, Maryland, New Jersey and North Dakota have or will soon join Delaware, Massachusetts and Virginia. 
 
Those states requiring third-party administration of furosemide (commonly referred as Lasix) on race day are anticipated to rise from 13 in January 2014 to at least 16 by early 2015 – a 23% increase. Arkansas, California, Oregon and Pennsylvania will join Colorado, Delaware, Indiana, Kentucky, Maine, Maryland, Massachusetts Minnesota, New Jersey, North Dakota, Virginia and West Virginia in implementing this policy which restricts access to the horse on race day.
 
“We are very encouraged by the industry’s willingness to embrace reform and urge all horse racing jurisdictions in the United States to adopt the reforms in their entirely without further delay,” said Alex Waldrop, chairman of the RMTC and president and CEO of the NTRA.
 
The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing. The organization works to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public.
 
For additional information, visit the RMTC website at rmtcnet.com.

Source: RMTC Press Release

 

comments powered by Disqus

Top Stories